NCT04194775: An ongoing trial by CStone Pharmaceuticals
This trial is ongoing. It must report results 6 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04194775 |
|---|---|
| Title | A Multi-Center, Double-Blind, Randomized, Phase III Study to Investigate the Efficacy and Safety of Nofazinlimab (CS1003) in Combination With Lenvatinib Compared to Placebo in Combination With Lenvatinib as First-Line Therapy in Subjects With Advanced Hepatocellular Carcinoma (HCC) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 13, 2019 |
| Completion date | June 18, 2025 |
| Required reporting date | June 18, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |